During the past decade, Twin Cities Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Twin Cities Clinical Research" are "Obesity" (2 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials), "Dyslipidemia" (1 trials), "Obesity in Diabetes" (1 trials) and "Renal Insufficiency, Chronic" (1 trials). Many other conditions were trialed in "Twin Cities Clinical Research" in a lesser frequency.

Most popular intervention types in "Twin Cities Clinical Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Rimonabant (SR141716)" (2 trials) and "paricalcitol capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Twin Cities Clinical Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Twin Cities Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Twin Cities Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Twin Cities Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".